Previous 10 | Next 10 |
Azenta, Inc. (AZTA) Q1 2022 Earnings Conference Call February 08, 2022, 16:30 ET Company Participants Sara Silverman - Director, IR Stephen Schwartz - CEO Lindon Robertson - EVP & CFO Conference Call Participants David Saxon - Needham & Company Jacob Johnson - Stephens Paul Knight - K...
Azenta press release (NASDAQ:AZTA): FQ1 Non-GAAP EPS of $0.12 beats by $0.04. Revenue of $140M (+18.6% Y/Y) beats by $4.57M. Adjusted EBITDA was $20 million and Adjusted EBITDA margin was 14.2%, down 130 basis points from the fourth quarter of 2021. For further details see: Azenta Non-G...
Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021 Continued Double-Digit Growth, Healthy End Markets, and a Strong Balance Sheet PR Newswire CHELMSFORD, Mass. , Feb. 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZT...
Azenta (NASDAQ:AZTA) is scheduled to announce Q1 earnings results on Tuesday, February 8th, after market close. The consensus EPS Estimate is $0.08 (-83.0% Y/Y) and the consensus Revenue Estimate is $135.43M (-45.8% Y/Y). Over the last 2 years, AZTA has beaten EPS estimates 63% of the time an...
AIZ, AMRK, AMX, APPS, ARI, ATGE, ATO, AZTA, BBD, CCK, CMG, CMP, CRSR, DCPH, DOCS, EGP, ENPH, ENTA, FLT, FMC, GAIN, GFS, HIW, HUBG, ICHR, INSP, ISR, JKHY, KREF, LBRT, LYFT, MNDT, NBR, NCR, NEWR, OMC, ONTO, PAYC, PEAK, PSEC, PTON, QGEN, SAVE, STE, SVM, TCS, TRMB, TRVG, TSE, UDR, USNA, VOYA, VRE...
Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference PR Newswire CHELMSFORD, M...
Azenta Life Sciences Completes Sale of Semiconductor Solutions Group Business to Thomas H. Lee Partners PR Newswire CHELMSFORD, Mass. , Feb. 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of...
Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and Webcast PR Newswire CHELMSFORD, Mass , Jan. 24, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 first quarter earnings which ended on...
Azenta Life Sciences Names Matthew McManus Chief Operating Officer PR Newswire CHELMSFORD, Mass. , Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effectiv...
MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBio’s HiFi sequencing platforms across Azenta’s newly com...
News, Short Squeeze, Breakout and More Instantly...
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON, Mass. , July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024 , on Tues...
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study PR Newswire Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. , July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) t...
2024-07-20 00:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...